Psychopharmakotherapie
SJR0.117
DE
DEJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.117 | Q4 | 6.1% | |
| 2024 | — | — | 0.109 | Q4 | 6.4% | |
| 2023 | — | — | 0.105 | Q4 | 11.3% | |
| 2022 | — | — | 0.111 | Q4 | 17.7% | |
| 2021 | — | — | 0.115 | Q4 | 21.6% | |
| 2020 | — | — | 0.118 | Q4 | 9.5% | |
| 2019 | — | — | 0.195 | Q3 | 37.8% | |
| 2018 | — | — | 0.154 | Q4 | 23.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
ISSN
0944-6877
country
DEcoverage
1996-2026